Affiliation:
1. From the Heart and Kidney Institute, University of Houston, Houston, Texas
Abstract
Oxidative stress plays a pathogenic role in hypertension, particularly the one associated with diabetes and obesity. Here, we test the hypothesis that renal dopamine D1 receptor dysfunction in obese Zucker rats is caused by oxidative stress. One group each from lean and obese Zucker rats received tempol, a superoxide dismutase mimetic in drinking water for 2 weeks. Obese animals were hypertensive, hyperglycemic, and hyperinsulinemic, exhibited renal oxidative stress, and increased protein kinase C activity. Also, there was hyperphosphorylation of D1 receptor, defective receptor–G-protein coupling, blunted dopamine-induced Na+-K+-ATPase inhibition, and diminished natriuretic response to D1 receptor agonist, SKF-38393. However, obese animals had elevated levels of plasma nitric oxide and urinary cGMP. In addition, l-N-nitroarginine and sodium nitroprusside showed similar effect on blood pressure in lean and obese rats. In obese animals, tempol reduced blood pressure, blood glucose, insulin, renal oxidative stress, and protein kinase C activity. Tempol also decreased D1 receptor phosphorylation and restored receptor G-protein coupling. Dopamine inhibited Na+-K+-ATPase activity, and SKF-38393 elicited a natriuretic response in tempol-treated obese rats. Thus in obese Zucker rats, tempol ameliorates oxidative stress and improves insulin sensitivity. Consequently, hyperphosphorylation of D1 receptor is reduced, leading to restoration of receptor–G-protein coupling and the natriuretic response to SKF-38393.
Publisher
American Diabetes Association
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference50 articles.
1. Epstein M, Sowers JR: Diabetes mellitus and hypertension. Hypertension 19:403–418,1992
2. Segers O, Anckaert E, Gerlo E, Dupont AG, Somers G: Dopamine-sodium relationship in type 2 diabetic patients. Diabetes Res Clin Pract 34:89–98,1996
3. Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christensen NJ, Bent-Hansen L, Nielsen MD: Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:610–617,1987
4. Shigetomi S, Yamada ZO, Ishii H, Sanada H, Watanabe H, Fukuchi S: Dopaminergic activity and endorenal dopamine synthesis in non-insulin dependent diabetes mellitus. Hypertens Res 19 (Suppl. 1):S125–S130,1995
5. Becker M, Umrani D, Lokhandwala MF, Hussain T: Increased renal angiotensin II AT1 receptor function in obese Zucker rat. Clin Exp Hypertens 25:35–47,2003
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献